Pawel Rajwa, Associate Professor at Centre of Postgraduate Medical Education, shared a post on X:

“Our new SR and MA published in European Urology Oncology evaluates focal therapy for localized PCa using prospective data only. Important for patient counselling.
50 studies, 4,615 patients.
12-mo csPCa RFS in intermediate-risk: 79% (95% CI 74–83%).”

“Outcomes of Focal Therapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies”

Authors: Aleksander Ślusarczyk, Pawel Rajwa et al.

Pawel Rajwa: Outcomes of Focal Therapy for Localized Prostate Cancer